Wang Sicong, Li Linfeng, Cheng Yuanda
Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Zhongguo Fei Ai Za Zhi. 2024 Jan 2;26(12):957-960. doi: 10.3779/j.issn.1009-3419.2023.106.25.
Ground-glass nodule (GGN) lung cancer often progresses slowly in clinical and there are few clinical studies on long-term follow-up of patients with operable GGN lung cancer treated with stereotactic body radiation therapy (SBRT). We present a successful case of GGN lung cancer treated with SBRT, but a new GGN was found in the lung adjacent to the SBRT target during follow-up. The nodule progressed rapidly and was confirmed as lung adenocarcinoma by surgical resection. No significant risk factors and related driving genes were found in molecular pathological findings and genetic tests. It deserves further study whether new GGN is related to the SBRT. This case suggests that the follow-up after SBRT should be vigilant against the occurrence of new rapidly progressive lung cancer in the target area and adjacent lung tissue. .
磨玻璃结节(GGN)型肺癌在临床上通常进展缓慢,关于可手术切除的GGN型肺癌患者接受立体定向体部放疗(SBRT)后的长期随访临床研究较少。我们报告1例成功接受SBRT治疗的GGN型肺癌病例,但在随访期间,在SBRT靶区相邻的肺组织中发现了一个新的GGN。该结节迅速进展,经手术切除确诊为肺腺癌。分子病理学检查结果和基因检测未发现明显的危险因素和相关驱动基因。新出现的GGN是否与SBRT有关值得进一步研究。该病例提示,SBRT后的随访应警惕靶区及相邻肺组织出现新的快速进展性肺癌。